LEADER 01491nam  2200409Ia 450 
001 9910695712703321
005 20070427135954.0
035   $a(CKB)5470000002372658
035   $a(OCoLC)123767530
035   $a(EXLCZ)995470000002372658
100   $a20070427d2007      ua             0
101 0 $aeng
135   $aurbn|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aEffects of medicare's drug pricing on other purchasers$b[electronic resource]
210  1$aWashington, DC :$cCongress of the United States, Congressional Budget Office,$d[2007]
300   $aTitle from title screen (viewed on Apr. 25, 2007).
300   $a"April 16, 2007."
517 1 $aLetter to the Honorable Debbie Stabenow
606   $aPharmaceutical services insurance$zUnited States
606   $aPrescription pricing$zUnited States
606   $aDrugs$xPrices$xLaw and legislation$zUnited States
606   $aOlder people$xPharmaceutical assistance$zUnited States
615  0$aPharmaceutical services insurance
615  0$aPrescription pricing
615  0$aDrugs$xPrices$xLaw and legislation
615  0$aOlder people$xPharmaceutical assistance
701   $aStabenow$b Debbie$01408665
712 02$aUnited States.$bCongressional Budget Office.
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910695712703321
996   $aEffects of medicare's drug pricing on other purchasers$93493125
997   $aUNINA